table of content
1 Study Coverage
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Introduction
1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Outlook 2017 VS 2022 VS 2028
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size for the Year 2017-2028
1.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size for the Year 2017-2028
1.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Over the Counter (OTC) Drugs & Dietary Supplements in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Over the Counter (OTC) Drugs & Dietary Supplements Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
1.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
1.4.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
1.4.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
1.4.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Over the Counter (OTC) Drugs & Dietary Supplements by Type
2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Segment by Type
2.1.1 Analgesic & Pain Relievers
2.1.2 Dermatological Products
2.1.3 Cough, Cold, and Flu Products
2.1.4 Vitamin Supplements
2.1.5 Mineral Supplements
2.1.6 Ophthalmic Products
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017, 2022 & 2028)
2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028)
2.4 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017, 2022 & 2028)
2.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028)
3 Over the Counter (OTC) Drugs & Dietary Supplements by Application
3.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacy
3.1.4 Others
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017, 2022 & 2028)
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028)
3.4 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017, 2022 & 2028)
3.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028)
4 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Company
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Company
4.1.1 Top Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Ranked by Revenue (2021)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Player (2017-2022)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Concentration Ratio (CR)
4.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Over the Counter (OTC) Drugs & Dietary Supplements in 2021
4.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Headquarters, Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Type
4.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Headquarters and Area Served
4.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Company
4.5.1 Top Over the Counter (OTC) Drugs & Dietary Supplements Players in United States, Ranked by Revenue (2021)
4.5.2 United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2020, 2021 & 2022)
5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2028)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017-2022
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.4.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Details
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.1.5 Pfizer Inc. Recent Development
7.2 Novartis International AG
7.2.1 Novartis International AG Company Details
7.2.2 Novartis International AG Business Overview
7.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.2.5 Novartis International AG Recent Development
7.3 Roche Holding AG
7.3.1 Roche Holding AG Company Details
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.3.5 Roche Holding AG Recent Development
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Details
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.4.5 Merck & Co., Inc. Recent Development
7.5 Sanofi S.A
7.5.1 Sanofi S.A Company Details
7.5.2 Sanofi S.A Business Overview
7.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.5.5 Sanofi S.A Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Details
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.6.5 Johnson & Johnson Recent Development
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Details
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.7.5 Gilead Sciences Recent Development
7.8 GlaxoSmithKline plc.
7.8.1 GlaxoSmithKline plc. Company Details
7.8.2 GlaxoSmithKline plc. Business Overview
7.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.8.5 GlaxoSmithKline plc. Recent Development
7.9 Bayer Healthcare AG
7.9.1 Bayer Healthcare AG Company Details
7.9.2 Bayer Healthcare AG Business Overview
7.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.9.5 Bayer Healthcare AG Recent Development
7.10 AstraZeneca plc.
7.10.1 AstraZeneca plc. Company Details
7.10.2 AstraZeneca plc. Business Overview
7.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.10.5 AstraZeneca plc. Recent Development
7.11 Alacer Corp.
7.11.1 Alacer Corp. Company Details
7.11.2 Alacer Corp. Business Overview
7.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.11.5 Alacer Corp. Recent Development
7.12 Alcon Inc.
7.12.1 Alcon Inc. Company Details
7.12.2 Alcon Inc. Business Overview
7.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.12.5 Alcon Inc. Recent Development
7.13 Alfresa Pharma Corporation
7.13.1 Alfresa Pharma Corporation Company Details
7.13.2 Alfresa Pharma Corporation Business Overview
7.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.13.5 Alfresa Pharma Corporation Recent Development
7.14 Alkalon A/S
7.14.1 Alkalon A/S Company Details
7.14.2 Alkalon A/S Business Overview
7.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.14.5 Alkalon A/S Recent Development
7.15 Alliance Healthcare
7.15.1 Alliance Healthcare Company Details
7.15.2 Alliance Healthcare Business Overview
7.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.15.5 Alliance Healthcare Recent Development
7.16 Allergan, Plc.
7.16.1 Allergan, Plc. Company Details
7.16.2 Allergan, Plc. Business Overview
7.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.16.5 Allergan, Plc. Recent Development
7.17 Reckitt Benckiser Plc.
7.17.1 Reckitt Benckiser Plc. Company Details
7.17.2 Reckitt Benckiser Plc. Business Overview
7.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.17.5 Reckitt Benckiser Plc. Recent Development
7.18 Bausch & Lomb
7.18.1 Bausch & Lomb Company Details
7.18.2 Bausch & Lomb Business Overview
7.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.18.5 Bausch & Lomb Recent Development
7.19 AbbVie Inc.
7.19.1 AbbVie Inc. Company Details
7.19.2 AbbVie Inc. Business Overview
7.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.19.5 AbbVie Inc. Recent Development
7.20 The Colgate-Palmolive Company
7.20.1 The Colgate-Palmolive Company Company Details
7.20.2 The Colgate-Palmolive Company Business Overview
7.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.20.5 The Colgate-Palmolive Company Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
